Equities researchers at StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a report issued on Thursday. The brokerage set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Price Performance
CO opened at $1.50 on Thursday. The company has a fifty day moving average price of $1.46 and a 200-day moving average price of $1.34. The firm has a market capitalization of $182.33 million, a P/E ratio of 2.34 and a beta of 0.16. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50.
About Global Cord Blood
Featured Articles
- Five stocks we like better than Global Cord Blood
- Buy P&G Now, Before It Sets A New All-Time High
- How Much Can You Make in Stocks in One Month?
- What is a Bond Market Holiday? How to Invest and Trade
- This Is the Top Large-Cap Stock Insiders Are Buying
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.